Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Pim Wetzelaer"'
Autor:
Anne Kleijburg, C. Louwrens Braal, Justin D. Westenberg, Agnes Jager, Stijn L.W. Koolen, Ron H.J. Mathijssen, Carin A. Uyl-de Groot, Pim Wetzelaer, Hannah Penton
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 158, Iss , Pp 114158- (2023)
The aim of this study was to describe health-related quality of life (HRQoL) and productivity in Dutch breast cancer patients treated with tamoxifen in an adjuvant setting. Patients who started treatment with a standard dose of tamoxifen and who gave
Externí odkaz:
https://doaj.org/article/75aa2aeba8954e90b4c1bc5405e57cff
Autor:
Pim Wetzelaer, Joan Farrell, Silvia M. A. A. Evers, Gitta A. Jacob, Christopher W. Lee, Odette Brand, Gerard van Breukelen, Eva Fassbinder, Heather Fretwell, R. Patrick Harper, Anna Lavender, George Lockwood, Ioannis A. Malogiannis, Ulrich Schweiger, Helen Startup, Teresa Stevenson, Gerhard Zarbock, Arnoud Arntz
Publikováno v:
BMC Psychiatry, Vol 22, Iss 1, Pp 1-2 (2022)
Externí odkaz:
https://doaj.org/article/29a050826b604db2afc2200609472f16
Autor:
Nigel Armstrong, Nasuh Büyükkaramikli, Hannah Penton, Rob Riemsma, Pim Wetzelaer, Vanesa Huertas Carrera, Stephanie Swift, Thea Drachen, Heike Raatz, Steve Ryder, Dhwani Shah, Titas Buksnys, Gill Worthy, Steven Duffy, Maiwenn Al, Jos Kleijnen
Publikováno v:
Health Technology Assessment, Vol 24, Iss 51 (2020)
Background: There have been no licensed treatment options in the UK for treating thrombocytopenia in people with chronic liver disease requiring surgery. Established management largely involves platelet transfusion prior to the procedure or as rescue
Externí odkaz:
https://doaj.org/article/c59e5b6200d84298a2c9f75acd4ef74a
Autor:
Karima Azdad, Marcelo Chàvez, Patrick Don Bischop, Pim Wetzelaer, Bart Marescau, Peter Paul De Deyn, David Gall, Serge N Schiffmann
Publikováno v:
PLoS ONE, Vol 4, Iss 9, p e6908 (2009)
The striatum is the major input structure of basal ganglia and is involved in adaptive control of behaviour through the selection of relevant informations. Dopaminergic neurons that innervate striatum die in Parkinson disease, leading to inefficient
Externí odkaz:
https://doaj.org/article/c1fc5708e7fd4ea0ab8f3fc58b655806
Autor:
Stefan Rabbe, Meilin Möllenkamp, Benedetta Pongiglione, Hedwig Blommestein, Pim Wetzelaer, Renaud Heine, Jonas Schreyögg
Publikováno v:
Health Economics (United Kingdom), 31(S1), 135-156. John Wiley & Sons Ltd.
Variation in healthcare utilization has been discussed extensively, with many studies showing that variation exists, but fewer studies investigating the underlying factors. In our study, we used a logistic multilevel-model at the patient, hospital, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b3043889631f4b93960a3d36694c628
https://doi.org/10.1002/hec.4492
https://doi.org/10.1002/hec.4492
Autor:
C. Louwrens Braal, Anne Kleijburg, Agnes Jager, Stijn L. W. Koolen, Ron H. J. Mathijssen, Isaac Corro Ramos, Pim Wetzelaer, Carin A. Uyl-de Groot
Publikováno v:
Clinical drug investigation, 42(2), 163-175. Adis International Ltd
Clinical Drug Investigation, 42(2), 163-175. Adis International Ltd
Braal, C L, Kleijburg, A, Jager, A, Koolen, S L W, Mathijssen, R H J, Corro Ramos, I, Wetzelaer, P & Uyl-de Groot, C A 2022, ' Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer : A Cost-Effectiveness Analysis from the Prospective TOTAM Trial ', Clinical drug investigation, vol. 42, no. 2, pp. 163-175 . https://doi.org/10.1007/s40261-021-01114-6
Clinical Drug Investigation, 42(2), 163-175. Adis
Clinical Drug Investigation, 42(2), 163-175. Adis International Ltd
Braal, C L, Kleijburg, A, Jager, A, Koolen, S L W, Mathijssen, R H J, Corro Ramos, I, Wetzelaer, P & Uyl-de Groot, C A 2022, ' Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer : A Cost-Effectiveness Analysis from the Prospective TOTAM Trial ', Clinical drug investigation, vol. 42, no. 2, pp. 163-175 . https://doi.org/10.1007/s40261-021-01114-6
Clinical Drug Investigation, 42(2), 163-175. Adis
Background and Objectives: Endoxifen is the active metabolite of tamoxifen, and a minimal plasma concentration of 16 nM has been suggested as a threshold above which it is effective in reducing the risk of breast cancer recurrence. The aim of the cur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::427f816b0df8221e29c1f87e3b99cc03
https://research.vumc.nl/en/publications/34a5d76e-d590-4a3a-8980-d1e17c4e2a29
https://research.vumc.nl/en/publications/34a5d76e-d590-4a3a-8980-d1e17c4e2a29
Autor:
C Louwrens, Braal, Anne, Kleijburg, Agnes, Jager, Stijn L W, Koolen, Ron H J, Mathijssen, Isaac, Corro Ramos, Pim, Wetzelaer, Carin A, Uyl-de Groot
Publikováno v:
Clinical drug investigation. 42(2)
Endoxifen is the active metabolite of tamoxifen, and a minimal plasma concentration of 16 nM has been suggested as a threshold above which it is effective in reducing the risk of breast cancer recurrence. The aim of the current analysis was to invest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::df3d6775092ad8c9e65433732ebc8a31
https://pubmed.ncbi.nlm.nih.gov/35020170
https://pubmed.ncbi.nlm.nih.gov/35020170
Autor:
Hannah Penton, Nasuh Büyükkaramikli, Jos Kleijnen, Gill Worthy, Steven Duffy, Steve Ryder, Titas Buksnys, Thea Drachen, Pim Wetzelaer, Nigel Armstrong, Heike Raatz, Stephanie L. Swift, Rob Riemsma, Maiwenn Al, Dhwani Shah, Vanesa Huertas Carrera
Publikováno v:
Health Technology Assessment, 51, 1-220. National Co-ordinating Centre for HTA
Health Technology Assessment, Vol 24, Iss 51 (2020)
Health Technol Assess
Health Technology Assessment, Vol 24, Iss 51 (2020)
Health Technol Assess
Background There have been no licensed treatment options in the UK for treating thrombocytopenia in people with chronic liver disease requiring surgery. Established management largely involves platelet transfusion prior to the procedure or as rescue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de94c75a4a96bbfabd9aba9f8517a359
https://pure.eur.nl/en/publications/c5bb39fc-3f45-4186-9409-e1da21c4e55f
https://pure.eur.nl/en/publications/c5bb39fc-3f45-4186-9409-e1da21c4e55f
Autor:
Mehmet Tonge, Ersoy Kocabicak, Linda Ackermans, Pieter L. Kubben, Silvia M. A. A. Evers, Tim A. M. Bouwens van der Vlis, Yasin Temel, Pim Wetzelaer
Publikováno v:
Turkish Neurosurgery, 28(6), 929-933. Turkish Neurosurgical Society
Evers, Silvia MAA/0000-0003-1026-570X; Tonge, Mehmet/0000-0002-0106-9363; Kubben, Pieter/0000-0002-8059-523X; Wetzelaer, Pim/0000-0002-7450-0046 WOS: 000450653000012 PubMed: 29465741 AIM: To investigate the costs of treating the infection with antibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd42ddb6be79fa721acf00ba40c42a14
https://cris.maastrichtuniversity.nl/en/publications/c50cc019-c59e-4153-8ce4-73b7d405e315
https://cris.maastrichtuniversity.nl/en/publications/c50cc019-c59e-4153-8ce4-73b7d405e315